Table 1.
HGV Exposure | HGV/RNA | Anti E2 | HbsAg | HBcAB | HCV RNA | Anti HCV | |
---|---|---|---|---|---|---|---|
Haemodialysis(34) Predialysis (66) |
23(67.6%) 28(42.4%) |
9 (26.5%) 9 (13.6%) |
14 (41.2%) 19 (28.8%) |
2 (5.9%) 3 (4.5%) |
2 (5.9%) 3 (4.5%) |
33 (97%) 25 (37.9%) |
32 (94.1%) 20 (30.3%) |
Total (100) | 51 (51%) | 18 (18%) | 33 (33%) | 5 (5%) | 5 (5%) | 58 (58%) | 52 (52%) |
Controls (25) | 2 (8%) | 1 (4%) | 1 (4%) | 0 | 0 | 0 | 0 |